The Current Ratio as of December 2025 (TTM) for Perspective Therapeutics, Inc. (CATX) is 15.09

According to Perspective Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 15.09. This represents a change of 10.98% compared to the average of 13.60 of the last 4 quarters.

Perspective Therapeutics, Inc. (CATX) Historical Current Ratio (quarterly & annually)

How has CATX Current Ratio performed in the past?

The mean historical Current Ratio of Perspective Therapeutics, Inc. over the last ten years is 11.21. The current 15.09 Current Ratio has changed 13.36% with respect to the historical average. Over the past ten years (40 quarters), CATX's Current Ratio was at its highest in in the June 2021 quarter at 37.37. The Current Ratio was at its lowest in in the December 2023 quarter at 1.07.

Perspective Therapeutics, Inc. (CATX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Perspective Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Perspective Therapeutics, Inc. (CATX) Average Current Ratio

How has CATX Current Ratio performed in the past?

The current Current Ratio of Perspective Therapeutics, Inc. (CATX) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Perspective Therapeutics, Inc. (CATX) Current Ratio vs. Peers

How is CATX’s Current Ratio compared to its peers?

Perspective Therapeutics, Inc.’s Current Ratio is greater than Profound Medical Corp. (8.53), greater than TriSalus Life Sciences, Inc. (3.05), greater than Nyxoah S.A. (1.70), less than Solana Company (40.03), greater than Invivyd, Inc. (2.47), greater than MaxCyte, Inc. (7.74), greater than Nano-X Imaging Ltd. (4.19), greater than Anteris Technologies Global Corp. (2.41), greater than Electromed, Inc. (4.31), greater than Neuronetics, Inc. (2.24),

Build a custom stock screener for Perspective Therapeutics, Inc. (CATX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Perspective Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Perspective Therapeutics, Inc. (CATX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Perspective Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.